Cargando…
Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes
Whether sitagliptin may increase thyroid cancer risk has not been investigated in the Asian populations. This study evaluated the association in Taiwanese patients with newly diagnosed type 2 diabetes from 1999 to 2008 by using the reimbursement database of the National Health Insurance. They should...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029749/ https://www.ncbi.nlm.nih.gov/pubmed/27029076 http://dx.doi.org/10.18632/oncotarget.8399 |